The number of requests for designation of orphan drugs has increased steadily over the past five years. FDA has approximately 200 requests for designation of orphan drugs that are pending...
This next 2 days, my colleague Andreas Bikfalvi, Prof. of Cell & Molecular Biology, will attend to the 7th congress of the French Association on Angiogenesis (SFA) to be held in Toulouse where he...
The Cancéropôle GSO is organizing a seminar on 30 and 31 March 2017 in Moissac around the theme "precision medicine, personalized medicine". The objective of these days is to better...
This week, my young fellow colleague Cyril Benoit, lecturer in Political Sciences, and me, are going to present at the International Health Policy Conference to be held at London School of Economics our working...
OECD release the "OECD Science, Technology and Innovation Outlook 2016" at European Commission in Brussels to inform policy makers and analysts on recent and future changes in global science, technology and innovation. I...
Next week, a conference on Economic Dimensions of Personalized and Precision Medicine (PPM) will be held on September 21 and 22 at Columbia University (NY, USA). Precision medicine, the targeting of therapies on...
This month University of Chicago Press release a National Bureau of Economic Research Conference Report. In this book edited by ERNST R. BERNDT (MIT), DANA P. GOLDMAN (USC), AND JOHN ROWE (Columbia U), we explores altogether the intersection...
The European Association of Health Economics (EuhEA) conference organized by the Hamburg Center for Health Economics is starting tomorrow. During a session on drug innovation, I will assess the feedback effects that post launch policies have on...
Serendipity is defined as the art of discovering, an unsought finding. It is one of the most important aspects of science, generating radical and disruptive innovations. I will present at the XVIIth...
This week, my young fellow colleague, Diego Useche, post-doc in the lab, is going to present in Copenhagen at the 20th Anniversary conference of DRUID Society our working paper on "Orphan drug designations as valuable intangible...